Contact Suneva Medical

News

Press Releases

05/14/13 Suneva Medical Announces Results of Its Pivotal ArteFill® Acne Scar Study
09/18/12 Suneva Medical Completes Enrollment and Initial Treatment of Patients in Phase III Acne Scar Study
06/06/12 Suneva Medical Introduces ReGenica™, the Next Generation of Growth Factor Skincare
05/21/12 Suneva Medical Acquires Product Portfolio from Spear Pharmaceuticals - Refissa Leads Suneva into the Topical Aesthetic Market
03/05/12 Histogen Signs License Agreement with Suneva Medical for Cell Conditioned Media-based Aesthetic Products
01/11/12 Suneva Medical to Pursue Expanded Indications for Artefill® with Launch of Phase III Acne Scar Study
11/01/11 Even in This Economy, Consumers Invest in Aesthetic Procedures With Long Lasting Results
06/29/11 Suneva Medical Announces Canadian Approval of Bellafill™
10/15/10 Nicholas L. Teti, Jr. Appointed President and CEO of Suneva Medical
10/07/10 New Study Published in Journal of Drugs in Dermatology Finds Artefill Effective in Treating Atrophic Acne Scars
05/07/10 Artefill® Featured on “The Doctors” Television Show
05/05/10 Suneva Medical Announces Publication of Artefill® Five-Year Safety and Patient Satisfaction Study Interim Results in Dermatologic Surgery
05/04/10 Leading Plastic Surgeons Report Positive Data on Artefill® at Key Society Meetings
02/16/10 Leading U.S. Dermatologist Reports Positive Data on Artefill®
02/02/10 Two Studies Find Artefill® to Be a Long-Term Treatment Option for Facial Lipoatrophy
01/25/10 Suneva Medical Announces Positive Interim Data from Five-Year Safety and Patient Satisfaction Study on Artefill®
01/18/10 Study Results Evaluating the Correction of Atrophic Scars with Artefill Presented at 2010 Orlando Dermatology Conference
12/17/09 Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment